Skip to Content
Merck
  • Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis.

Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2013-06-05)
Nobuaki Ochi, Hiromichi Yamane, Tomoko Yamagishi, Yasumasa Monobe, Nagio Takigawa
PMID23733760
MATERIALS
Product Number
Brand
Product Description
M9929
Sigma-Aldrich
Methotrexate, meets USP testing specifications
06563
Sigma-Aldrich
Methotrexate hydrate, ≥99.0% (sum of enantiomers, HPLC)
M8407
Sigma-Aldrich
Methotrexate hydrate, powder, BioReagent, suitable for cell culture, ≥98% (HPLC)
A6770
Sigma-Aldrich
Methotrexate hydrate, ≥98% (HPLC), powder